Radioprotection of targeted and bystander cells by methylproamine.

Area of Science:

• Radiation biology
• Cellular radiobiology
• Radioprotective agents

Background:

• Radioprotective agents are crucial for cancer radiotherapy and public health in accidental radiation exposure scenarios.
• Methylproamine, a DNA-binding antioxidant, aids in repairing radiation-induced oxidative DNA damage.
• This study investigates methylproamine's efficacy in protecting both directly irradiated and bystander cells.

Purpose of the Study:

• To evaluate the radioprotective potential of methylproamine on directly targeted cells.
• To assess the radioprotective effects of methylproamine on bystander cells exposed to radiation-induced signals.
• To compare methylproamine's effectiveness against different types of radiation, including gamma rays, X-rays, and helium ions.

Main Methods:

• T98G glioma cells were treated with 15 μM methylproamine.
• Cells were exposed to (137)Cs γ-ray/X-ray irradiation and He(2+) microbeam irradiation.
• Radioprotection was quantified using clonogenic survival assays and γH2AX staining.

Main Results:

• Methylproamine demonstrated radioprotection for directly targeted cells exposed to γ-rays and X-rays, but not He(2+) ions.
• Bystander cell protection was observed when recipient cells were pretreated with methylproamine before exposure to conditioned medium from irradiated cells.
• In co-culture microbeam experiments, methylproamine treatment during and after irradiation protected bystander cells.

Conclusions:

• Methylproamine effectively protects targeted cells from γ-ray and X-ray-induced DNA damage.
• The radioprotective effect on bystander cells was independent of the radiation type the donor cells received.
• Methylproamine shows promise as a radioprotector for both directly targeted and bystander cells in specific radiation contexts.